Results 121 to 130 of about 2,616,272 (289)

Recuperación del bloque neuromuscular. Parámetros clínicos, ventilatorios y uso de la aceleromiografía en pacientes sometidos a anestesia general inhalatoria

open access: yes, 2014
Determinar cuáles parámetros clínicos y ventilatorios de recuperación del bloqueo neuromuscular, uso monitorización de la relajación neuromuscular emplean los especialistas en anestesiología de los siguientes centros hospitalarios: Hospital “Dr.
Hernández Alvarado, Ninoska Fabiola   +1 more
core  

Initial Stay Time and Work‐Rest Scheduling During Consecutive Heavy‐Intensity Workdays in Hot Environments in Young and Older Males

open access: yesAmerican Journal of Industrial Medicine, EarlyView.
ABSTRACT Introduction This study examined initial stay times (IST), defined as the duration of uninterrupted work before core temperature approaches recommended safety limits (38.0°C, ~1.0°C above baseline), and the efficacy of work‐rest cycles during repeated heavy work across consecutive workdays in young and older males.
Glen P. Kenny   +6 more
wiley   +1 more source

Evidence-Based Guidelines for Intraoperative Quantitative Neuromuscular Monitoring [PDF]

open access: yes
Nondepolarizing neuromuscular blocking agents are routinely used medications vital to anesthetic care. When administering neuromuscular blocking agents, monitoring neuromuscular blockade depth and degree of recovery is a standard of nurse anesthesia ...
Graham, Noah
core  

Musculoskeletal Phenotypes of 19 Patients With X‐Linked HNRNPH2‐Related Neurodevelopmental Disorder: A Prospective Case Series

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Detailed clinical phenotypes have been previously reported for 33 individuals with X‐linked HNRNPH2‐related neurodevelopmental disorder. Of these, 75% self‐reported a musculoskeletal abnormality, including hip dysplasia, scoliosis, kyphosis, lordosis, pes planus, arthritis, and missing spinous processes.
Ambar Garcia   +6 more
wiley   +1 more source

Immune Modulatory Therapy for Severe Dengue Hemorrhagic Fever in a Patient With Mitochondrial Complex I Deficiency: A Case Report

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Dengue virus (DENV) poses a serious global health challenge, particularly in cases of dengue hemorrhagic fever (DHF). Patients with preexisting mitochondrial disorders may be at increased risk for complications due to the specific impact of DENV on mitochondrial‐dependent cellular processes and immune function.
Audra N. Iness   +11 more
wiley   +1 more source

Neuromuscular blockade in the elderly patient

open access: yes, 2016
Luis A Lee, Vassilis Athanassoglou, Jaideep J Pandit Nuffield Department of Anaesthetics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK Abstract: Neuromuscular blockade is a desirable or even essential component of general ...
Lee LA, Athanassoglou V, Pandit JJ
core  

Extreme levels of noise constitute a key neuromuscular deficit in the elderly

open access: yes, 2012
Fluctuations during isometric force production tasks occur due to the inability of musculature to generate purely constant submaximal forces and are considered to be an estimation of neuromuscular noise.
William R Taylor   +19 more
core   +1 more source

COX14 Variants Are Associated With Mitochondrial Complex IV Deficiency Nuclear Type 10 (MC4DN10)

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT COX14 encodes a transmembrane protein essential for cytochrome c oxidase (COX) complex assembly. A homozygous missense variant in COX14 was reported in three siblings from a single consanguineous family with severe, fatal infantile mitochondrial complex IV deficiency nuclear type 10 (MC4DN10; MIM# 619053).
Elias K. Awad   +7 more
wiley   +1 more source

Monitoring Neuromuscular Blockade

open access: yesInternational Anesthesiology Clinics, 2004
Glenn S, Murphy, Joseph W, Szokol
openaire   +2 more sources

Integrating Genetic Modifier Genotype With Serum Proteomics in Duchenne Muscular Dystrophy Clinical Trials Links LTBP4 Genetic Modifier to IL‐23/CD93 Pathways in Muscle

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Genetic modifiers of Duchenne muscular dystrophy (DMD) that alter disease severity or response to therapy have been reported using natural history or registry data sets of older corticosteroid‐treated patients. We tested associations of genetic modifiers on motor function outcomes in young (4 to < 7 years) steroid naïve clinical trial ...
Utkarsh J. Dang   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy